IDA has a wealth of experience in a broad range of therapeutic areas:

Indication Stategic/ KOL Regulatory/ Product Development ICC/CTN PHASE 1 PHASE 2-3 / Observ. MAH (ODD, SAKIGAKE, NDA) Partnering Support
CNS
CIDP
Fibromyalgia
Insomnia
Narcolepsy
Stroke (AIS)
Stroke (SAH)
Cardiovascular
ACS
Arteriosclerosis
Arterial Fibrillation
Ischemia
PAH
Dermatology
Acne
Aesthetic Injectable
Atopic Dermatitis
Hematology
Acute Bleeding
Bleeding Control
Hemophilia
Infectious Disease
MRSA
Onychomycosis
Metabolic
Diabetes
Diabetic Neuropathy
HOFH
Musculoskeletal
Gout
Osteoporosis
Rheumatoid Arthritis
Oncology
Brain Cancer
CCA/BTC (Orphan)
CSCC (Orphan)
HCC
Mesothelioma
NSCLC
NHL (Orphan)
Pancreatic Cancer
Prostate Cancer
Radiation Dermatitis
SCLC
Ophthalmology
Allergy
AMD
Anti-infective
Corneal EC Protection
Dry Eye
Post-Op Inflammation
Orphan Disease
AA Amyloidosis
AL Amyloidosis
Alport Syndrome
Hereditary Angioedema
Lupus Nephritis
Mitochondrial Disease
Paroxysmal Nocturnal Hemoglobinuria
Pyruvate Kinase Deficiency
Prader Willi Syndrome
Primary Biliary Cirrhosis
sIBM
Other
Allergy (DNA Vaccine)
COPD
Enuresis & Nocturia
General Anesthesia
GVHD (Cell Therapy)
Copyright © 2017 Covance Inc. All rights reserved.